Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040 — Yubin Kang (2023) | RDL Network
Todd S. Crocenzi, Anthony B. El-Khoueiry, Thomas Cheung Yau, Ignacio Melero, Bruno Sangro, Masatoshi Kudo, Chiun Hsu, Jörg Trojan, Tae‐You Kim, Su Pin Choo, Tim Meyer, Yoon‐Koo Kang, Winnie Yeo, Akhil Chopra, Adyb Baakili, Christine Marie Dela Cruz, Lixin Lang, Jaclyn Neely, Theodore H. Welling
Ignacio Melero, Thomas Yau, Yoon‐Koo Kang, T.-Y. Kim, Armando Santoro, B. Sangro, Masatoshi Kudo, Ming Hou, Ana Matilla, Francesco Tovoli, Jennifer J. Knox, Aiwu Ruth He, Bassel F. El‐Rayes, M. Acosta-Rivera, Ho Yeong Lim, S. Soleymani, J. Yao, Jaclyn Neely, M. Tschaika, Chiun Hsu, Anthony B. El-Khoueiry
Bruno Sangro, Aiwu Ruth He, Thomas Yau, Chiun Hsu, Yoon‐Koo Kang, Tae‐You Kim, Armando Santoro, Ignacio Melero, Masatoshi Kudo, M. Ho, Ana Matilla, Francesco Tovoli, Jennifer J. Knox, Bassel F. El‐Rayes, Mirelis Rivera Acosta, Jaclyn Neely, Yun Shen, Marina Tschaika, Anthony El-Khoureiry
Ignacio Melero, Bruno Sangro, Thomas Cheung Yau, Chiun Hsu, Masatoshi Kudo, Todd S. Crocenzi, Tae‐You Kim, Su Pin Choo, Jörg Trojan, Tim Meyer, Theodore H. Welling, Winnie Yeo, Akhil Chopra, Jeffrey Anderson, Christine Marie Dela Cruz, Lixin Lang, Jaclyn Neely, Hao Tang, Anthony B. El-Khoueiry
Discussion(0)
No comments yet. Be the first to comment.